Erik Bloomquist
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
-
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 10
- Renal cell carcinoma treatment 6
- Oncology 11
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Marc A. Suchard (5 shared papers)Vladimir N. Minin (1 shared paper)Richard Pazdur (26 shared papers)Laleh Amiri‐Kordestani (21 shared papers)Julia A. Beaver (18 shared papers)Rajeshwari Sridhara (15 shared papers)Shenghui Tang (23 shared papers)Amna Ibrahim (13 shared papers)
- Journals
- Clinical Cancer Research (9 papers)Journal of Clinical Oncology (7 papers)The Oncologist (3 papers)The Lancet Oncology (2 papers)Systematic Biology (2 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Erik Bloomquist
33 papers receiving 2.1k citations
Erik Bloomquist's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 681
- Pulmonary and Respiratory Medicine 672
- Cancer Research 260
- Virology 73
- Genetics 391
Countries citing papers authored by Erik Bloomquist
This map shows the geographic impact of Erik Bloomquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Bloomquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Bloomquist more than expected).
Fields of papers citing papers by Erik Bloomquist
This network shows the impact of papers produced by Erik Bloomquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Bloomquist. The network helps show where Erik Bloomquist may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Bloomquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Smooth Skyride through a Rough Skyline: Bayesian Coalescent-Based Inference of Population Dynamics Hit paper breakdown → | 2008 | 541 |
| 2 | 2015 | 283 | |
| 3 | 2019 | 205 | |
| 4 | 2020 | 133 | |
| 5 | 2019 | 114 | |
| 6 | 2016 | 109 | |
| 7 | 2011 | 100 | |
| 8 | 2018 | 92 | |
| 9 | 2010 | 85 | |
| 10 | 2020 | 67 | |
| 11 | 2019 | 55 | |
| 12 | 2006 | 46 | |
| 13 | 2023 | 40 | |
| 14 | 2009 | 40 | |
| 15 | 2023 | 38 | |
| 16 | 2015 | 33 | |
| 17 | 2021 | 23 | |
| 18 | 2020 | 17 | |
| 19 | 2021 | 15 | |
| 20 | 2018 | 13 |
About Erik Bloomquist
Erik Bloomquist is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Surgery, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (10 papers), Renal cell carcinoma treatment (6 papers), Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Treatment and Pharmacology (4 papers), BRCA gene mutations in cancer (3 papers) and Genomics and Phylogenetic Studies (3 papers). The work is most often cited by research in Oncology (681 citations), Pulmonary and Respiratory Medicine (672 citations), Cancer Research (260 citations), Virology (73 citations) and Genetics (391 citations). Erik Bloomquist has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Marc A. Suchard, Vladimir N. Minin, Richard Pazdur, Laleh Amiri‐Kordestani, Julia A. Beaver, Rajeshwari Sridhara, Shenghui Tang, Amna Ibrahim, Paul G. Kluetz and Suparna Wedam. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, The Oncologist, The Lancet Oncology and Systematic Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.